Keresteci A G, Leers W D
Can Med Assoc J. 1973 Oct 20;109(8):711-3.
A "catheter team", consisting of two hospital assistants specially trained to catheterize male patients, inserted indwelling catheters in 435 men over a two-year period. The infection rate was 33%; in the 200 patients not treated with antimicrobial drugs (study group) the rate was 37%, while in the 235 patients who were so treated (antibacterial group) the infection rate was 29%. Fifty percent of patients not treated were infected after 6.3 days, whereas in patients on antibacterial therapy a 50% infection rate was not reached until 14 days after insertion. Therefore, no antibacterial therapy is necessary if it is anticipated that the catheter will be necessary for less than four days. On the other hand, prophylactic antibacterial therapy would delay the onset of infection considerably if catheterization were expected to continue for more than four days. Sulfisoxazole was our drug of choice for prophylactic treatment.
一个由两名经过专门培训为男性患者插导尿管的医院护工组成的“导尿管小组”,在两年时间里为435名男性插入了留置导尿管。感染率为33%;在未接受抗菌药物治疗的200名患者(研究组)中,感染率为37%,而在接受了抗菌药物治疗的235名患者(抗菌组)中,感染率为29%。未接受治疗的患者中有50%在6.3天后被感染,而接受抗菌治疗的患者直到插入导尿管14天后才达到50%的感染率。因此,如果预计导尿管使用时间少于4天,则无需进行抗菌治疗。另一方面,如果预计导尿将持续超过4天,预防性抗菌治疗将大大延迟感染的发生。磺胺异恶唑是我们预防性治疗的首选药物。